Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study

Hdl Handle:
http://hdl.handle.net/10144/344032
Title:
Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study
Authors:
Rohner, Eliane; Valeri, Fabio; Maskew, Mhairi; Prozesky, Hans; Rabie, Helena; Garone, Daniela; Dickinson, Diana; Chimbetete, Cleophas; Lumano-Mulenga, Priscilla; Sikazwe, Izukanji; Wyss, Natascha; Clough-Gorr, Kerri M; Egger, Matthias; Chi, Benjamin H; Bohlius, Julia
Journal:
Journal of Acquired Immune Deficiency Syndromes
Abstract:
The risk of Kaposi sarcoma (KS) among HIV-infected persons on antiretroviral therapy (ART) is not well defined in resource-limited settings. We studied KS incidence rates and associated risk factors in children and adults on ART in Southern Africa.
Publisher:
Lippincott Williams & Wilkins
Issue Date:
15-Dec-2014
URI:
http://hdl.handle.net/10144/344032
DOI:
10.1097/QAI.0000000000000360
PubMed ID:
25393941
Language:
en
Description:
Awaiting permission from the publisher.
ISSN:
1944-7884
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorRohner, Elianeen_GB
dc.contributor.authorValeri, Fabioen_GB
dc.contributor.authorMaskew, Mhairien_GB
dc.contributor.authorProzesky, Hansen_GB
dc.contributor.authorRabie, Helenaen_GB
dc.contributor.authorGarone, Danielaen_GB
dc.contributor.authorDickinson, Dianaen_GB
dc.contributor.authorChimbetete, Cleophasen_GB
dc.contributor.authorLumano-Mulenga, Priscillaen_GB
dc.contributor.authorSikazwe, Izukanjien_GB
dc.contributor.authorWyss, Nataschaen_GB
dc.contributor.authorClough-Gorr, Kerri Men_GB
dc.contributor.authorEgger, Matthiasen_GB
dc.contributor.authorChi, Benjamin Hen_GB
dc.contributor.authorBohlius, Juliaen_GB
dc.date.accessioned2015-02-01T16:30:00Z-
dc.date.available2015-02-01T16:30:00Z-
dc.date.issued2014-12-15-
dc.identifier.citationIncidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study. 2014, 67 (5):547-54 J. Acquir. Immune Defic. Syndr.en_GB
dc.identifier.issn1944-7884-
dc.identifier.pmid25393941-
dc.identifier.doi10.1097/QAI.0000000000000360-
dc.identifier.urihttp://hdl.handle.net/10144/344032-
dc.descriptionAwaiting permission from the publisher.en_GB
dc.description.abstractThe risk of Kaposi sarcoma (KS) among HIV-infected persons on antiretroviral therapy (ART) is not well defined in resource-limited settings. We studied KS incidence rates and associated risk factors in children and adults on ART in Southern Africa.en_GB
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.titleIncidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Studyen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromesen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.